Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Birutė Galdikas: The last of the ‘angels’ in primatology’s most extraordinary chapter - 2How to sound like an astronaut as you follow the first human moon mission in more than half a century
- 3Every year, she thanks the trooper for the arrest that led to her sobriety
- 4Putin says Russian forces will seize capital of Zaporizhzhya
- 5African nations push to recognize crimes of colonialism in Algeria
- East Germany Somehow Built a Real Sports Car and It Was Wild
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- New Cheetos and Doritos will be free of artificial dyes
- 4 Excellent Remote Headphones of 2024
- Pick Your #1 Kind Of Treat
- 6 Top of the line Lodgings All over The Planet, Which One Do You Concur With
- Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- 5 Most Expected Film Delivery
- Former Israeli judge does not expect Netanyahu to be pardoned
